Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
By: Nasdaq / GlobeNewswire - 24 Feb 2017Back to overview list

Reference is made to the stock exchange notice of 10 February 2017 regarding the board of directors' resolution to increase the share capital in Targovax ASA (the "Company") in connection with the exercise of employee options and settlement of RSUs.

The share capital increase has today been registered in the Register of Business Enterprises (Nw.: Foretaksregisteret). The new registered share capital in the Company is NOK 4,219,971.90 comprising of 42,199,719 shares with a par value of NOK 0.10 per share.

For further information please contact:
Øystein Soug
CEO
Phone: +47 906 56 525
Email: oystein.soug@targovax.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Targovax ASA via GlobeNewswire

HUG#2081795
Related companies:Circio Holding ASA
Copyright 2017 Nasdaq / GlobeNewswire Back to overview list
to the top ↑